Literature DB >> 8111962

Alterations in the concentration of an apolipoprotein E-containing subfraction of plasma high density lipoprotein in coronary heart disease.

H M Wilson1, J C Patel, D Russell, E R Skinner.   

Abstract

The concentrations of high density lipoprotein (HDL) subfractions in 100 healthy male subjects were compared with 100 newly presenting patients with myocardial infarction (MI) within 12 h of the onset of chest pain. A subfraction of HDL enriched in apolipoprotein E (apo E), separated by heparin-Sepharose affinity chromatography, was present in lower concentrations (P < 0.001) in the plasma of the coronary patients than in the control subjects. This finding was confirmed by a lower content (P < 0.02) of apo E, measured by ELISA, in the total HDL fraction isolated from the coronary patients. Gradient gel electrophoresis of the total HDL demonstrated that the coronary patients had a significantly decreased concentration of the large HDL particles, HDL2b, of mean diameter 10.57 nm and a higher concentration of the smaller-sized HDL3, especially HDL3c, of mean diameter 7.62 nm. The coronary patients had a lower concentration of HDL cholesterol than the control subjects, attributable to the HDL2 fraction, with no difference in HDL2a between the two groups. There was no difference in the concentration of plasma cholesterol or triglyceride. The distribution of apo E phenotypes was similar in the two groups. HDL2b produced the highest discriminant power between the two groups, followed by apo E-rich HDL, HDL2 and HDL3c Plasma cholesterol correlated strongly with apo E-rich HDL for control subjects but not for MI survivors. This study demonstrates that the inverse relationship between HDL cholesterol and coronary risk shown in epidemiological studies is attributable to the large, apo E-containing HDL subspecies which under some circumstances are implicated in cholesterol removal by reverse cholesterol transport. This study also suggests that the concentration of the large, apo E-containing HDL may provide a sensitive predictor for subjects at risk of developing coronary heart disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8111962     DOI: 10.1016/0009-8981(93)90046-7

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  11 in total

1.  Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL.

Authors:  Tomas Vaisar; Subramaniam Pennathur; Pattie S Green; Sina A Gharib; Andrew N Hoofnagle; Marian C Cheung; Jaeman Byun; Simona Vuletic; Sean Kassim; Pragya Singh; Helen Chea; Robert H Knopp; John Brunzell; Randolph Geary; Alan Chait; Xue-Qiao Zhao; Keith Elkon; Santica Marcovina; Paul Ridker; John F Oram; Jay W Heinecke
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

2.  Does simultaneous determination of LDL and HDL particle size improve prediction of coronary artery disease risk?

Authors:  Aleksandra Zeljkovic; Vesna Spasojevic-Kalimanovska; Jelena Vekic; Zorana Jelic-Ivanovic; Aleksandra Topic; Natasa Bogavac-Stanojevic; Slavica Spasic; Ana Vujovic; Dimitra Kalimanovska-Ostric
Journal:  Clin Exp Med       Date:  2008-07-11       Impact factor: 3.984

3.  Apolipoproteins E and CIII interact to regulate HDL metabolism and coronary heart disease risk.

Authors:  Allyson M Morton; Manja Koch; Carlos O Mendivil; Jeremy D Furtado; Anne Tjønneland; Kim Overvad; Liyun Wang; Majken K Jensen; Frank M Sacks
Journal:  JCI Insight       Date:  2018-02-22

4.  Evaluation of the apolipoprotein E (apoE)-HDL-associated risk factors for coronary heart disease using duo-functional electrochemical aptasensor.

Authors:  Ching-Ying Tsai; Deng-Ying Huang; Ja-An Annie Ho; Li-Chen Wu
Journal:  Anal Bioanal Chem       Date:  2022-04-01       Impact factor: 4.142

5.  Obesity favors apolipoprotein E- and C-III-containing high density lipoprotein subfractions associated with risk of heart disease.

Authors:  Beatriz Talayero; Liyun Wang; Jeremy Furtado; Vincent J Carey; George A Bray; Frank M Sacks
Journal:  J Lipid Res       Date:  2014-06-25       Impact factor: 5.922

6.  Comparison of Postprandial Responses to a High-Fat Meal in Hypertriglyceridemic Men and Women before and after Treatment with Fenofibrate in the Genetics and Lipid Lowering Drugs and Diet Network (GOLDN) Study.

Authors:  Stephen P Glasser; Mary K Wojczynski; A I Oberman; Edmond K Kabagambe; Michael Y Tsai; Jose M Ordovas; Robert J Straka; Donna K Arnett
Journal:  SRX Pharmacol       Date:  2010

7.  Uptake of apolipoprotein E-rich and apolipoprotein E-poor subfractions of high-density lipoprotein by liver membranes and HepG2 cells.

Authors:  Y D Fragoso; E R Skinner
Journal:  Biochem J       Date:  1995-10-15       Impact factor: 3.857

8.  Plasma LDL and HDL characteristics and carotenoid content are positively influenced by egg consumption in an elderly population.

Authors:  Christine M Greene; David Waters; Richard M Clark; John H Contois; Maria Luz Fernandez
Journal:  Nutr Metab (Lond)       Date:  2006-01-06       Impact factor: 4.169

9.  Association of apolipoprotein E polymorphism with plasma lipid disorders, independent of obesity-related traits in Vietnamese children.

Authors:  Nguyen Thi Hong Hanh; Bui Thi Nhung; Duong Thi Anh Dao; Le Thi Tuyet; Le Thi Hop; Tran Quang Binh; Vu Thi Minh Thuc
Journal:  Lipids Health Dis       Date:  2016-10-10       Impact factor: 3.876

10.  Impact of APOE gene polymorphisms on the lipid profile in an Algerian population.

Authors:  Houssam Boulenouar; Sounnia Mediene Benchekor; Djabaria Naïma Meroufel; Sarah Aicha Lardjam Hetraf; Hadjira Ouhaibi Djellouli; Xavier Hermant; Benjamin Grenier-Boley; Imane Hamani Medjaoui; Nadhira Saidi Mehtar; Philippe Amouyel; Leila Houti; Aline Meirhaeghe; Louisa Goumidi
Journal:  Lipids Health Dis       Date:  2013-10-25       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.